Bayer reported €33.02B in Equity Capital and Reserves for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akzo Nobel AKZA:NA € 5425M 84M
Alcon AG ALC:SW 19.26B 163M
Arkema AKE:FP € 6303M 246M
AstraZeneca AZN:LN 39268M 476M
BASF BAS:GR € 39392M 2109M
Bayer BAYN:GR € 33020M 1917M
Covestro 1COV:GR 7.7B 484M
Fresenius FRE:GR € 18998M 697M
Genmab GEN:DC DK 22719M 523M
Givaudan GIVN:VX 3.93B 277M
GRIFOLS GRF:SM € 5168.17M 254.92M
Hikma Pharmaceutical HIK:LN 2.45B 163M
Johnson Matthey JMAT:LN 2.67B 12M
Linde LIN:GR € 44035M 288M
Lonza Group LONN:SW 9.75B 2.48B
Novartis NOVN:VX SF 67655M 10884M
Philips PHIA:NA € 14439M 122M
SAP SAP:GR € 38959M 3757M
Solvay SOLB:BB € 8739M 381M
Umicore UMI:BB 3.11B 231M